Table 6.
Risk factors (# Patients) | Coefficients (SE) | Relative risk (95%CI) | P-values1 |
t/n TRFLR | 0.78 (0.37) | (1.06-4.48) | 0.035 |
≤85% (n = 57) | 1 | ||
>85% (n = 17) | 2.18 | ||
T-status | 1.17 (0.78) | (0.70-15.06) | 0.134 |
T1+T2 (n = 13) | 1 | ||
T3+T4 (n = 61) | 3.24 | ||
N-status | 1.06 (0.66) | (0.79-10.48) | 0.108 |
N0 (n = 24) | 1 | ||
N1+N2 (n = 50) | 2.88 | ||
M-status | 0.87 (0.43) | (1.03-5.49) | 0.042 |
M0 (n = 60) | 1 | ||
M1 (n = 14 ) | 2.38 | ||
Stage | -0.90 (0.78) | (0.09-1.89) | 0.251 |
I+II (n = 27) | 1 | ||
III+IV (n = 47) | 0.41 | ||
Differentiation | 0.33 (0.35) | (0.70-2.76) | 0.352 |
W+M (n = 25) | 1 | ||
P (n = 49) | 1.39 | ||
Telomerase expression | -0.11 (0.46) | (0.36-2.22) | 0.811 |
Negative (n = 11) | 1 | ||
Positive (n = 63) | 0.9 |
Wald statistic